DATAS Studien - Literaturnachweis

Dual Chamber & Atrial Tachyarrhythmias Adverse Event Study

1. Berstein, A.D., Camm A.J., Fisher J.D. et al. The North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG Defibrillation Code, Pacing Clin Electrophysiol; 1993, 16, 1776-80.

2. The AVID investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.

3. Moss AJ, Hall J, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N.Engl J Med 1996; 335:1933-1940.

4. Buxton AE, Kerry L. Lee, Ph.D., John D. Fisher, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N. Engl J Med 1999; 341:1882-90

5. Swygman C, Homoud M, Link M, Wang P, Mark Estes III.Technologic advances in implantable cardioverter defibrillators. Curr Opin Cardiol 1999; 14:9-14.

6. Santini M, Ansalone G, Auriti A, Magris B, Pandozi C, Altamura G. Indications for Dual Chamber ( DDD) pacing in ICD patients. Am J Cardiol. 1996;78:116-118.

7. Calkins H, Brinker J, Veltri E, Levine JH. Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators. J Am Coll Cardiol 1990;16:666-673.

8. Epstein AE, Kay GN, Plumb VJ, Shepard RB, Kirklin JK. Combined automatic implantable cardioverter defibrillator and pacemaker systems: implantation techniques and folow-up. J Am Coll Cardiol 1989;13:121-131.

9. Reiter MJ, Hindman MC. Hemodynamic effects of acute atrioventricular sequential pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992;19:1542-1549.

10. Grimm W, Flores B, Marchlinski. Electrocardiographically documented unnecessary, sponatenousshocks in 241 patients with implantable cardioverter defibrillators. PACE 1992; 15:1667-73

11. Schmitt C, Montero M, Melichercik J. Significance o supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. PACE 1994;17:295-302.

12. Neuzner J, Petschner HF.Managing the problem of atrial tachyarrhythmias in patients with ICDs. Practice and Progress in Cardiac Pacing and Electrophysiology; 1996 Kluwer Academic Publishers:353-360.

13. Resuscitative Shocks (CEDARS) Study: Does Atrial Fibrillation Increase the incidence of inappropriate Shock by Implanted Defibrillators? JACC 1993 Feb;21(Nº2) 201 A.

14. Neuzner J, Pitschner HF, Konig S, Stohring R, Schlepper M. Stored electrogram in Cardioveter-Defibrillator therapy: accuracy of rhythm diagnosis in 335 spontaneous arrhythmia episodes.

15. Best PJ, Hales DL, Stanton MS. The Potential Usage of Dual Chamber Pacing in Patients with Implantable Cardioverter Defibrillators. PACE 1999; 22: 79-85.

16. Higgins S, Williams S, Pak J, Meyer D. Indication for a Dual Chamber pacemarker combined with an implantable Cardioverter-Defibrillator. Am J Cardiol.; 81: 1360-1362.

17. Shenasa H, Shenasa M. Conversion of atrial fibrillation to sinus rhythm during implantable cardioverter-defibrillator discharges: incidence and implications. European Heart Journal Aug 1996; 17:( Abstr Suppl):479.

18. Osswald S, Cron TA, Sterns L, Alt E, Stotts L, Coenen M. New ICD-Technologies: First Clinical Experience with Dual-Cahmber Sensing for differentiation of supraventricular Tachyarrhythmias. PACE 1998 Jan; 21 (Pt 2):292-295.

19. Wolf PA, Abbot RD, Kannel WB. Atrial fibrillation as independent risk factor for stroke: The Framingham Heart Study. Stroke 1991; 22:983-988.

20. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow up Study. Am J Med 1995; 98:476-484.

21. Feinberg WM, Blackshear JL, Lapaucis A, Kronmal R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155:469-473.

22. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith, Rautaharju PM. Prevalence of atrial fibrillation in the elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74:236-241.

23. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100(4):376-80

24. Komajda M, Jais J, Reeves F, Goldfarb B, Bouhour J, Juillieres Y et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J 1990;11:824-831.

25. McKenna W. Arrythmia and prognosis in hypertrophic cardiomyopathy. Eur Heart J 1983;4 (Suppl F):225-234.

26. Wolpert et al. Circulation 1999; 100:Y368 Abstract.

27. Wellens HJJ, Lau Ch-P, Lüderitz B, Akhart M, Waldo AL, Camm AJ et al. Atrioverter: An Implantable Device for Treatment of Atrial Fibrillation. Circulation 1998;98:1651-1656.

28. Geelen P, Lorga A, Ghauvin M, Wellens F, Brugada P. The value of DDD pacing in patients with an ICD. PACE 1997; 20: 177-181.

29. Schuller J, Brandt J. The Opacemarker Syndrome: Old and New Causes. Clin. Cardiol 1991;14:336-340.

30. Pacífico A, Hohnloser S, Williams J, Tao B, Saksena S, P Henry et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999; 340:1855-62.

31. Roelke M, Garan H, McGovern BA, Ruskin J. Analysis of the initation of spontaneous ventricular tachycardia by stored electrograms.J. Am Coll Cardiol 1994;23:117-122.

32. Marchlinski FE, Callans DJ, Gottlieb CD, Schwartzman D, Preminger M. Benefits and lessons learned from stored electrogram information in Implantable defibrillators. J. Cardiovasc. Electrophysiol 1995; 832-851.

33. Stabile G, Senatore G, De Simone A, Turco P, Coltorti F, Nocerino P et al. Determinants of Efficacy of Atrial Pacing in Preventing Atrial Fibrillation Recurrences. J Cardiovasc Electrophysiol. 1999;10:2-9.

34. Attuel P, Pellerin D, Mugica, Coumel P. DDD pacing: an effective treatment modality for recurrent atrial arrythmias. PACE 1988; 11:1647-1654.

35. Ramdat Misier AR, Beukema WP, Oude Luttikhuis HA. Multisite or Alternate Site Pacing for the Prevention of Atrial Fibrillation. Am J Cardiol. 1999;83:237D-240D.

36. Delfaut Ph, Saksena S, Prakash A, Krol RB. Long-Term Outcome of Patients With Drug-Refractory Atrial Flutter and Fibrillation After Single- and Dual-Site Right Atrial Pacing for Arrhythmia Prevention. J Am Coll Cardiol. 1998;32:1900-1908.

37. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T y cols. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-16.

38. Camm J, Ward D. Pacing for tachycardia control. Londres. Telectronics, 1983; 59-65.

39. Wellens HJJ, Lau Ch-P, Lüderitz B, Akhart M, Waldo AL, Camm AJ et al. Atrioverter: An Implantable Device for Treatment of Atrial Fibrillation. Circulation 1998;98:1651-1656.

40. Lévy S, Ricard Ph, Gueunoun M, Yapo F, Trigano J, Mansouri Ch y cols. Low-Energy Cardioversion of Spontaneus Atrial Fibrillation: Immediate and Long-term Results. Circulation. 1997,96:253-259.

41. Duytschaever M, Haerynck F, Tavernier R, Jordaens L. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation. PACE 1998;21:284-287.

42. Josephson ME. New Approaches to the Management of Atrial Fibrillation: The Role of the Atrial Defibrillator (editorial). Circulation 1998;98:1594-1596.Kjl

43. Mayet J, More RS, Sutton GC. Anticoagulation for cardioversion of atrial arrhythmias. European Heart J: 1998; 19: 548-552.

44. Medtronic Jewel AF Model 7250 PMA Report, 1999.

45. Goette A, Honeycutt C, Langberg J. Electrical Modeling in Atrial Fibrillation: Time Course and Mechanisms. Circulation 1996; 92:1954-68

46. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allesie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92:1954-68.

47. Goette A, Honeycutt C, Langberg JL. Electrical Remodeling in Atrial Fibrillation: Time Course and Mechanisms. Circulation 1996;96:2968-74

48. Daound EG, Bogun F, Goyal R et al. Effect of atrial Fibrillation on Atrial Refractoriness in humans. Circulation 1996; 94: 1600-6.

49. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices. JACC 1998; 31; 1175-1209.